Clinical & Laboratory markers as predictors for severity and mortality in COVID-19
Polytechnic Journal · 01.09.2023 · 13 (1)
DOI: 10.59341/2707-7799.1746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polytechnic Journal, online erschienen am 01.09.2023. Verfasst von Asma Ameen Ghareeb und 1 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Backgrounds: COVID-19, a new health challenge, can be diagnosed by many laboratory biomarkers. Biomarkers became valuable for prognosis; identifying the severity and mortality of the disease in COVID-19 patients. This study aims to determine the association of clinical, demographics, and laboratory biomarkers (CRP, D-dimer, lymphocyte, and platelet) with the severity and mortality of COVID-19.
Methods
Between June 1st and November 1st, 2020, 34 healthy controls and 104 COVID-19 cases were enrolled in this study. SARS-CoV-2 infection was confirmed using the real-time RT-PCR technique. All cases were analyzed for clinical, epidemiological, and laboratory biomarkers. COVID-19 cases were regrouped into mild (n=40), moderate (n=32), and severe (n=32) groups depending on the severity of the disease; it was also re-categorized into survivor (n=85) and non-survivor (n=19) groups depending on mortality. After collecting blood from participants, hematological parameters (lymphocyte and platelet) and other biomarkers (CRP and D-dimer) were measured by colter and Cobas c111, respectively.
Results
For age categories and comorbidities, Statistical significance was found among COVID-19 groups. Regarding ABO, Rh, and gender, a non-significant difference was found among groups of COVID-19 patients. Cough and headache i the most common symptom in our population. SpO2 depressed more significantly in severe and moderate groups than in mild groups. Severe and moderate groups exhibit higher CRP, D-dimer, and lymphocyte percentages than control while there was a non-significant change for platelets and absolute lymphocyte counts among studies groups. All studied laboratory biomarkers were higher in non-survivors than in survivor COVID-19 groups. A significant correlation was found between D-dimer and other laboratory biomarkers.
Conclusion
Gender, ABO, and Rh were not associated but age and comorbidities were associated with the severity of COVID-19. All studied laboratory biomarkers were associated with mortality.
Zitieren
APA
Ghareeb, A. A., & Abdulaziz, S. M. (2023). Clinical & Laboratory markers as predictors for severity and mortality in COVID-19. Polytechnic Journal, 13(1). https://doi.org/10.59341/2707-7799.1746
Vancouver
Ghareeb AA, Abdulaziz SM. Clinical & Laboratory markers as predictors for severity and mortality in COVID-19. Polytechnic Journal. 2023;13(1). doi:10.59341/2707-7799.1746
BibTeX
@article{Ghareeb2023,
author = {Ghareeb, Asma Ameen and Abdulaziz, Sazan Moffaq},
title = {Clinical & Laboratory markers as predictors for severity and mortality in COVID-19},
journal = {Polytechnic Journal},
year = {2023},
volume = {13},
number = {1},
doi = {10.59341/2707-7799.1746}
}
EUVIMED